Heba Fastighets AB (publ) (LON:0GNV)
29.50
+0.03 (0.09%)
At close: Dec 15, 2025
Heba Fastighets AB Revenue
Heba Fastighets AB had revenue of 150.20M SEK in the quarter ending September 30, 2025, with 4.52% growth. This brings the company's revenue in the last twelve months to 625.63M, up 21.29% year-over-year. In the year 2024, Heba Fastighets AB had annual revenue of 553.13M, down -10.43%.
Revenue (ttm)
625.63M SEK
Revenue Growth
+21.29%
P/S Ratio
7.93
Revenue / Employee
14.55M SEK
Employees
43
Market Cap
391.54M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 553.13M | -64.40M | -10.43% |
| Dec 31, 2023 | 617.53M | 108.81M | 21.39% |
| Dec 31, 2022 | 508.72M | 59.93M | 13.35% |
| Dec 31, 2021 | 448.80M | 55.04M | 13.98% |
| Dec 31, 2020 | 393.76M | 5.39M | 1.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |